Maternal Vitamin D Status and Neonatal Bone Strength

NCT ID: NCT01630603

Last Updated: 2013-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives:

1. To determine the incidence of vitamin D deficiency among Israeli pregnant women
2. To access whether maternal vitamin D status affects infant bone strength.

Methods:

1. Vitamin D levels -in cord blood and maternal blood
2. The mother will fill a demographic and nutritional questionnaire

The Infants:
3. Growth assessment of the infants: weight length and head circumference
4. Bone strength measurement by Quantitative Ultrasound (Sunlight Omnisense 7000/8000TM)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Maternal Vitamin D Status Neonatal Bone Quantitative Ultrasound Measurements

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mother infants pairs

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* mother-baby pairs,
* birth week 35-42.
* Jewish and Arab women that read and understand Hebrew.

Exclusion Criteria

* large neonatal congenital defects.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Meir Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Meir Medical Center

Kfar Saba, , Israel

Site Status RECRUITING

Meir Medical Center

Kfar Saba, , Israel

Site Status RECRUITING

Neonatal department Meir Medical Center

Kfar Saba, , Israel

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ita Litmanovich, MD

Role: CONTACT

09-7471554

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ita Litmanovitz Litmanovitz, MD

Role: primary

Ita Litmanovits

Role: primary

09-7471154

Ita Litmanovich, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MMC14-12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Vitamin D Supplementation in Breastfeeding Women
NCT01240265 COMPLETED PHASE2/PHASE3
Vitamin D in Pregnancy and Lactation
NCT01112891 COMPLETED PHASE4
Prevention of Vitamin D Deficiency
NCT00494104 COMPLETED NA